u/anya_erdogan

the column you will wish you had is sleep

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.

System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.

no clinical trial has established what these threads assert

ask the supplier what documentation accompanies the shipment

Right, and the payoff arrives around month six when a pattern becomes visible that nobody could hold in their head.

That reads like a titration plan and this board cannot give you one. Somebody who actually knows your history has to.

Assumed regulatory status was static and it was not. Checked again this year and the answer had changed where I live.

Left up.

dose_diary_dana is right about blanks. Silent gaps make the series lie.

UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.

Purity by area percent tells you the sample is homogeneous.

Adding the standing caveat — research material is not approved for human use, wherever you are.

Added a sleep column late and immediately understood two of my worst weeks.

Agreed — and the payoff genuinely arrives in month six, not week two.

staying at 0.5mg for an extra month is a legitimate plan

That figure cannot be quoted to two decimals off that baseline. The precision is not in the data.

Is the concentration recorded anywhere in the log?

Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.

This. Mass spectrometry for identity, not just an area percent, because a pure something-else is still something else.

staying at 0.25mg for an extra month is a legitimate plan

Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.

How old is the column and roughly how many injections has it seen?

retention time alone is not identity

personal import rules are not the same as commercial import rules

research-use-only labelling is not a customs category

Delayed gastric emptying is most pronounced early and attenuates with continued dosing, which is why the early fullness usually fades at a stable dose.

Did protein intake change in the same window?

the scale is the least sensitive instrument you own

Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.

axis labels or the trace is decoration

you cannot report to two decimals off that baseline

Right, and clearance time is not carrier time. Blaming the shipper for a customs queue is a category error.

nausea that arrives on day two and fades by day four is the standard shape

Sceptical of the mechanism you are proposing. Gastric emptying slows, it does not stop, and the timings you describe do not follow from it.

two labs, two gradients, two honest answers

UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.

How long was the stall before you decided it was a stall?

system suitability before you believe any number on the run

That figure cannot be quoted to two decimals off that baseline. The precision is not in the data.

First month I lost almost nothing and nearly quit. Month two and three were where it all happened.

reproducibility beats resolution if you only get one of them

no clinical trial has established what these threads assert